Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology

被引:78
|
作者
Scheff, Stephen W. [1 ]
Ansari, Mubeen A. [1 ]
Mufson, Elliott J. [2 ]
机构
[1] Univ Kentucky, Dept Anat & Neurobiol, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[2] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA
关键词
Synapses; Neurodegeneration; Dementia; Aging; Amyloid; Hippocampus; Temporal lobe; AMYLOID-BETA-PROTEIN; FRONTOTEMPORAL LOBAR DEGENERATION; ABNORMAL MITOCHONDRIAL DYNAMICS; MULTIPLE BRAIN-REGIONS; LIPID-PEROXIDATION; A-BETA; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; FRONTAL-CORTEX; TAU-PROTEIN;
D O I
10.1016/j.neurobiolaging.2016.02.030
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Neuritic amyloid plaques and neurofibrillary tangles are hallmarks of Alzheimer's disease (AD) and are major components used for the clinical diagnosis of this disorder. However, many individuals with no cognitive impairment (NCI) also present at autopsy with high levels of these AD pathologic hallmarks. In this study, we evaluated 15 autopsy cases from NCI individuals with high levels of AD-like pathology (high pathology no cognitive impairment) and compared them to age-and postmortem-matched cohorts of individuals with amnestic mild cognitive impairment and NCI cases with low AD-like pathology (low pathology no cognitive impairment [LPNCI]). Individuals classified as high pathology no cognitive impairment or amnestic mild cognitive impairment had a significant loss of both presynaptic and postsynaptic proteins in the hippocampus compared with those in the LPNCI cohort. In addition, these 2 groups had a significant increase in 3 different markers of oxidative stress compared with that in the LPNCI group. The changes in levels of synaptic proteins are strongly associated with levels of oxidative stress. These data suggest that cognitively older subjects without dementia but with increased levels of AD-like pathology may represent a very early preclinical stage of AD. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [1] Sex differences in the neuropathological hallmarks of Alzheimer's disease: focus on cognitively intact elderly individuals
    Hu, Yu-Ting
    Boonstra, Jackson
    McGurran, Hugo
    Stormmesand, Jochem
    Sluiter, Arja
    Balesar, Rawien
    Verwer, Ronald
    Swaab, Dick
    Bao, Ai-Min
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2021, 47 (07) : 958 - 966
  • [2] Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
    Tonnies, Eric
    Trushina, Eugenia
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1105 - 1121
  • [3] Tau as the Converging Protein between Chronic Stress and Alzheimer's Disease Synaptic Pathology
    Sotiropoulos, Ioannis
    Sousa, Nuno
    NEURODEGENERATIVE DISEASES, 2016, 16 (1-2) : 22 - 25
  • [4] Retinal vascular fractal analysis in cognitively intact individuals at risk for Alzheimer's Disease
    Graff, Jordan Taylor
    Badr, Amro
    Woodruff, Bryan
    Caselli, Richard
    Li, Xin
    Sobczak, Jacob
    Chen, John J.
    Wang, Yalin
    Dumitrascu, Oana
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [5] Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease
    Smith, CD
    Andersen, AH
    Kryscio, RJ
    Schmitt, FA
    Kindy, MS
    Blonder, LX
    Avison, MJ
    NEUROLOGY, 1999, 53 (07) : 1391 - 1396
  • [6] Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology
    Bjorklund, Nicole L.
    Reese, Lindsay C.
    Sadagoparamanujam, V-M
    Ghirardi, Valeria
    Woltjer, Randall L.
    Taglialatela, Giulio
    MOLECULAR NEURODEGENERATION, 2012, 7
  • [7] Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer’s disease neuropathology
    Nicole L Bjorklund
    Lindsay C Reese
    V-M Sadagoparamanujam
    Valeria Ghirardi
    Randall L Woltjer
    Giulio Taglialatela
    Molecular Neurodegeneration, 7
  • [8] Synaptic pathology in Alzheimer's disease
    Davisson, P
    Blennow, K
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 39 - 46
  • [9] Synaptic pathology in Alzheimer's disease
    Davidsson, P
    Blennow, K
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S3 - S3
  • [10] Synaptic pathology in Alzheimer's disease
    Marie, H.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 35 - 35